Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Protalix BioTherapeutics has entered into a non-binding term sheet with SarcoMed USA Inc.
read more
Tuesday, November 03, 2020
Protagonist Therapeutics announced two additional oral peptide IL-23 receptor antagonist candidates from its collaboration agreement with Janssen Biotech have been selected for advancement into clinical development.
read more
Protagen Protein Services GmbH and BioAnalytix announced a merger that will transform the combined company into a global analytic services provider for the biopharmaceutical industry.
read more
Wednesday, February 12, 2020
Protagen Protein Services (PPS) announced the appointment of Dr. Roland Moussa, as Chief Operating Officer.
read more
Protagen Protein Services (PPS) announced that it will merge with GeneWerk, an Ampersand portfolio company. With the addition of GeneWerk’s unique capabilities in vector safety, characterization, and functionality analysis, PPS will complement its ...
read more
Wednesday, December 14, 2016
PROTAGEN AG, a provider of pharma development services, companion diagnostics and novel diagnostic tests in the fields of immuno-oncology and autoimmune disease, has announced the launch of NavigAID SSc, a disease stratification assay designed to ...
read more
Tuesday, December 20, 2016
PROTAGEN AG, a provider of pharma development services, novel diagnostic tests and companion diagnostics in the fields of immuno-oncology and autoimmune disease, today has announced the successful completion a collaboration agreement with Novartis ...
read more
ProSciento announced the appointment of Dr. Kelvin Logan, former President of Europe, Asia and Latin America at INC Research, to its Board of Directors.
read more
Wednesday, December 10, 2025
ProRx Pharma announced a major expansion of its operations with the addition of new clean rooms, automation, and robotic technologies.
read more
ProQR Therapeutics, a company dedicated to changing lives through transformative RNA therapies, announced new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical proof of concept data for its...
read more
Takeda and Shire announced they have reached agreement on the terms of a recommended offer pursuant to which Takeda will acquire the entire share capital of Shire.
read more
Thursday, December 11, 2025
ProPharma, a provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Odyssey Investment Partners, announced the official inauguration of its new office in Hyderabad, India.
read more
Propanc Biopharma, Inc. a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, announced that synthetic recombinant proenzymes trypsinogen and chymotrypsinogen were successfully ...
read more
Wednesday, January 02, 2019
Propanc Biopharma announced that a cooperation agreement has been entered into between the University of Jaén and Propanc to begin the POP1 joint drug discovery program.
read more
PromoCell has successfully completed a comprehensive EXCiPACT audit that certifies the company as a manufacturer of pharmaceutical excipients to GMP standards.
read more